Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity. Predicted to be involved in ceramide metabolic process; glycoprotein metabolic process; and oligosaccharide metabolic process. Predicted to act upstream of or within lipid metabolic process. Predicted to be located in nucleoplasm. Is expressed in several structures, including exocrine gland; genitourinary system; hemolymphoid system gland; intestine; and nervous system. Orthologous to human ST6GALNAC3 (ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3).